Search

Kyle J Moody

Examiner (ID: 8172, Phone: (571)272-5242 , Office: P/2838 )

Most Active Art Unit
2838
Art Unit(s)
2838
Total Applications
778
Issued Applications
667
Pending Applications
60
Abandoned Applications
51

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18981357 [patent_doc_number] => 11906521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-20 [patent_title] => Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen [patent_app_type] => utility [patent_app_number] => 17/482918 [patent_app_country] => US [patent_app_date] => 2021-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 7396 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482918 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/482918
Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen Sep 22, 2021 Issued
Array ( [id] => 18931107 [patent_doc_number] => 11883501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Selective CXCR4 binding peptide conjugate and methods for making and using the same [patent_app_type] => utility [patent_app_number] => 17/479920 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13621 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479920 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479920
Selective CXCR4 binding peptide conjugate and methods for making and using the same Sep 19, 2021 Issued
Array ( [id] => 19425073 [patent_doc_number] => 12084476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-10 [patent_title] => Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors [patent_app_type] => utility [patent_app_number] => 17/476041 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18904 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476041 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/476041
Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors Sep 14, 2021 Issued
Array ( [id] => 19026333 [patent_doc_number] => 11925673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-12 [patent_title] => Treatment of age-related macular degeneration [patent_app_type] => utility [patent_app_number] => 17/471446 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 9059 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471446 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/471446
Treatment of age-related macular degeneration Sep 9, 2021 Issued
Array ( [id] => 17458784 [patent_doc_number] => 20220072088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => REDUCING CLOSTRIDIUM PERFRINGENS VIRULENCE USING INHIBITORS OF AGR-LIKE QUORUM SENSING [patent_app_type] => utility [patent_app_number] => 17/470775 [patent_app_country] => US [patent_app_date] => 2021-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470775 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/470775
REDUCING CLOSTRIDIUM PERFRINGENS VIRULENCE USING INHIBITORS OF AGR-LIKE QUORUM SENSING Sep 8, 2021 Pending
Array ( [id] => 19505010 [patent_doc_number] => 12116421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-15 [patent_title] => Peptide-based Dopa containing adhesive gels [patent_app_type] => utility [patent_app_number] => 18/021645 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 45 [patent_no_of_words] => 14086 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021645 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/021645
Peptide-based Dopa containing adhesive gels Sep 1, 2021 Issued
Array ( [id] => 17541024 [patent_doc_number] => 11306135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-19 [patent_title] => Anti-VEGF protein compositions and methods for producing the same [patent_app_type] => utility [patent_app_number] => 17/460578 [patent_app_country] => US [patent_app_date] => 2021-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 86 [patent_no_of_words] => 67810 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460578 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/460578
Anti-VEGF protein compositions and methods for producing the same Aug 29, 2021 Issued
Array ( [id] => 19354103 [patent_doc_number] => 12054532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-06 [patent_title] => Anti-VEGF protein compositions and methods for producing the same [patent_app_type] => utility [patent_app_number] => 17/458519 [patent_app_country] => US [patent_app_date] => 2021-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 86 [patent_no_of_words] => 67460 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458519 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/458519
Anti-VEGF protein compositions and methods for producing the same Aug 25, 2021 Issued
Array ( [id] => 17428366 [patent_doc_number] => 20220056074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES [patent_app_type] => utility [patent_app_number] => 17/401434 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401434
PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES Aug 12, 2021 Pending
Array ( [id] => 17760020 [patent_doc_number] => 20220233632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => MODULATORS OF COMPLEMENT ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/400267 [patent_app_country] => US [patent_app_date] => 2021-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400267 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/400267
Modulators of complement activity Aug 11, 2021 Issued
Array ( [id] => 17214492 [patent_doc_number] => 20210347829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => ARC-BASED CAPSIDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/382092 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32028 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382092 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/382092
Endogenous Gag-based capsids and uses thereof Jul 20, 2021 Issued
Array ( [id] => 17443704 [patent_doc_number] => 20220064209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS OF PURIFYING POLYPEPTIDES [patent_app_type] => utility [patent_app_number] => 17/369765 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31115 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369765 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/369765
METHODS OF PURIFYING POLYPEPTIDES Jul 6, 2021 Pending
Array ( [id] => 18177909 [patent_doc_number] => 20230038638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => COMPLEMENT FACTOR I-RELATED COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/347442 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55653 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347442 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347442
Complement factor I-related compositions and methods Jun 13, 2021 Issued
Array ( [id] => 17110193 [patent_doc_number] => 20210290790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHOD FOR PRODUCING PROTEIN COMPOSITION, AND PROTEIN COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/336672 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336672 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/336672
Method for producing protein composition, and protein composition Jun 1, 2021 Issued
Array ( [id] => 17776566 [patent_doc_number] => 20220242915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => SODIUM CHANNEL PROTEIN NAV1.4-TARGETING POLYPEPTIDE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/329194 [patent_app_country] => US [patent_app_date] => 2021-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3075 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329194 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/329194
Sodium channel protein Nav1.4-targeting polypeptide and use thereof May 24, 2021 Issued
Array ( [id] => 17428372 [patent_doc_number] => 20220056080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => Muramyl Peptide Derivatives [patent_app_type] => utility [patent_app_number] => 17/328078 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13133 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328078 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328078
Muramyl Peptide Derivatives May 23, 2021 Pending
Array ( [id] => 17082051 [patent_doc_number] => 20210277057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/328045 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328045 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328045
ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS May 23, 2021 Pending
Array ( [id] => 17185231 [patent_doc_number] => 20210332116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => SINGLE DOMAIN BINDING MOLECULE [patent_app_type] => utility [patent_app_number] => 17/322139 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322139 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/322139
Single domain binding molecule May 16, 2021 Issued
Array ( [id] => 17299479 [patent_doc_number] => 20210395318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => MULTISPECIFIC PROTEINS [patent_app_type] => utility [patent_app_number] => 17/302898 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302898 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/302898
MULTISPECIFIC PROTEINS May 13, 2021 Pending
Array ( [id] => 17228912 [patent_doc_number] => 20210355468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA [patent_app_type] => utility [patent_app_number] => 17/320386 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26686 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320386 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320386
COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA May 13, 2021 Abandoned
Menu